Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qing Bi granule
- Development stage
- Unknown
- Lead developer
- First Hospital of China Medical University
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Qing Bi granule is a Traditional Chinese Medicine (TCM) herbal compound developed by The First Affiliated Hospital of China Medical University. It is formulated for external (topical) application to treat inflammatory joint conditions associated with 'heat syndrome' in TCM, including osteoarthritis, rheumatoid arthritis, and gouty arthritis. The preparation is intended to alleviate clinical symptoms such as pain, redness, and swelling. In clinical studies, it has been evaluated for its onset time and therapeutic efficacy in comparison to conventional topical non-steroidal anti-inflammatory drugs (NSAIDs) like diclofenac (Futalin emulsion). As a complex herbal mixture, it likely exerts its effects through multi-target anti-inflammatory and analgesic pathways mediated by various phytochemical constituents.
- Other names
- Qingbi granuleQingbi granules
Beyond the preview
Go deeper on Qing Bi granule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qing Bi granule.